Ubie is a Tokyo based health-tech startup, that provides AI-based healthcare products, hospital SaaS products, and AI symptom checkers.
Ubie is a developer of an AI (Artificial Intelligence) symptom checker software that will provide its patients with individualized evaluation reports.Ubie provides AI-based healthcare products such as the hospital SaaS product, “Ubie for Hospital”, also known as AI Monshin (Monshin means an interview with a doctor/record taking in Japanese) is an AI-driven medical questionnaire software targeting users at medical institutions, in order to support document creation of clinical records under supervision from specialists.Ubie was established on May 1, 2017 by Kota Kubo, and Yoshinori Abe MD in Nihonbashi Muromachi, Tokyo .
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Series C | $17.10M | 4 | — | — | Detail |
Dec 8, 2022 | Debt Financing | $1.90M | 3 | — | — | Detail |
Aug 22, 2022 | Series C | $26.20M | 4 | Dai-ichi Life Egg Forward The Norinchukin Bank | — | Detail |
Jan 8, 2021 | Series B | ¥1.10B | — | — | — | Detail |
Sep 7, 2020 | Non-Equity Assistant | — | 1 | Google for Startups | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Dai-ichi Life | Yes | Series C |
Egg Forward | Yes | Series C |
The Norinchukin Bank | Yes | Series C |
Google for Startups | Yes | Non-Equity Assistant |
K4 Ventures | Yes | Series A |
D4V | Yes | Seed |
AAIC Investment Pte Ltd | — | Series C |
Japan Impact Investment II Limited Partnership | — | Series C |
Rakuten Capital | — | Series C |
Sogo Medical | — | Series C |